FDA advisory panel says widely used decongestant considered ineffective
An advisory panel for the U.S. Food and Drug Administration decided Tuesday an ingredient widely used in nasal decongestants doesn't work any better than a placebo pill.
China risks should get disclosed by large US companies, says former SEC chair
Former SEC chair Jay Clayton told the House Select Committee on the Chinese Communist Party that U.S. businesses should start disclosing their exposure to China for investors' benefit.
Federal judge rules against CFPB's anti-discrimination effort
A federal judge ruled that the Consumer Financial Protection Bureau overstepped its authority by looking to pursue regulatory actions related to anti-discrimination efforts.
Chip war heats up: China to launch $40B state fund for semiconductor manufacturing
China is planning a new $40 billion government-backed investment fund aimed at bolstering the country's semiconductor manufacturing industry that has been hit by U.S. export controls.
Narcan nasal spray is available for over-the-counter purchase in US: ‘Lifesaving drug’
Narcan (naloxone) is now available for purchase over the counter (OTC), without a prescription, in all U.S. states, Washington, D.C. and Puerto Rico. Here are details.
Federal appeals court revives lawsuit saying FDA overstepped on anti-ivermectin messaging
A federal appeals court has ruled that a lawsuit against the Food and Drug Administration for advocating against Ivermectin use can proceed.
Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drug
Assistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.
Regulators propose changes to ‘living wills’ and debt rules for big banks in wake of crisis
Federal financial regulators proposed new rules for large banks that aren't classified as systemically important related to their long-term debt holdings and their "living wills."
What the 10 drugs subject to Medicare price negotiations currently cost
President Biden announced the first 10 Medicare Part D drugs his administration has selected for price negotiation, including blood thinner Eliquis and Jardiance, a diabetes medication.
Facebook owner Meta, forced to pay nearly $100K per day for violation, is still breaking rule, regulator says
Meta Platforms should continue paying a daily fee of nearly $100,000 as it remains in violation of the European General Data Protection Regulation, a Norwegian regulator argued.
North Korea resumes limited commercial flights to China in major step to reopening borders
North Korea requires significant financial support following three years of strict border closures over COVID-19 fears, which the country claimed to have eradicated last year.
CRISIS IN KENSINGTON: Businesses setting up 'booby traps' for protection
In Kensington's open-air drug market, some businesses struggle to entice prospective customers as drug users loiter or pass out on their front stoops.
China's economy is sick and could infect the US
China's economic slowdown looks likely to worsen, a reality that could inflict some pain on U.S. companies highly reliant on their business with the country.
Global wealth drops for first time since 2008
Credit Suisse and UBS's Global Wealth Report finds global wealth fell last year for the first time since 2008, with the U.S. leading in market losses.
Sam Bankman-Fried siphoned $100M stolen from customers into US politics to influence crypto legislation: feds
FTX founder Sam Bankman-Fried is accused through a superseding indictment of using stolen customer funds in a "wide-ranging political influence operation."
US manufacturing sector reaping benefits of reshoring
The U.S. manufacturing sector is benefitting from firms reshoring their operations from overseas back to the U.S. as they try to mitigate vulnerabilities in their supply chains.
Novo Nordisk's Wegovy faces supply constraints as demand surges
Novo Nordisk said lower-dose strengths of Wegovy will be limited as it tries to ramp up production to meet the surge in demand for the weight loss drug.
Biden’s new tax could squash my family's can company
An Ohio steel conglomerate's plan threatens tens of thousands of U.S. manufacturing jobs and would increase the price of canned goods across the country.
Supreme Court temporarily blocks Purdue Pharma bankruptcy deal protecting Sackler family from lawsuits
The Supreme Court on Aug. 10, 2023, temporarily blocked a bankruptcy deal that would protect the Sackler family, who owns Purdue Pharma, manufacturer of Oxycontin, from lawsuits.
China slides into deflation in potentially worrying sign for global economy
As many countries deal with crippling inflation, China is seeing month-on-month declines in consumer prices and spending stoking anxiety among investors and trading partners.